LyP-1 conjugated nanoparticles for magnetic resonance imaging of triple negative breast cancer

From National Research Council Canada

DOIResolve DOI:
AuthorSearch for: 1; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for:
  1. National Research Council of Canada. Human Health Therapeutics
FormatText, Article
Subjectbreast cancer; triple negative; MRI; optical imaging; LyP1 peptide; iron oxide nanoparticles; molecular imaging
Publication date
NoteCorrection to: LyP-1 Conjugated Nanoparticles for Magnetic Resonance Imaging of Triple Negative Breast Cancer (Molecular Imaging and Biology, (2018), 20, 3, (428-435), 10.1007/s11307-017-1140-4)
Peer reviewedYes
NPARC number23002408
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifierb815ac89-5ce5-4802-a507-d5495ca2bfb1
Record created2017-11-06
Record modified2020-03-16
Date modified: